loader
Please Wait
Applying Filters...
Close
4

Seqens Seqens

X

Information, Expiry & Status of Health Canada Patents covering Lisdexamfetamine Dimesylate.

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Gowling Lafleur Henderson LLP (1)

02 Gowling WLG (Canada) LLP (6)

filter

01 2527646 (7)

filter

01 LISDEXAMFETAMINE DIMESYLATE (2)

02 Lisdexamfetamine Dimesylate (5)

filter

01 CAPSULE (2)

02 Capsule (5)

filter

01 2024-01-06 (7)

Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2527646
60 mg
Capsule
Human
2024-01-06
2011-08-23
2004-01-06
VYVANSE
Oral
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2527646
30 mg
Capsule
Human
2024-01-06
2011-08-23
2004-01-06
VYVANSE
Oral
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2527646
50 mg
Capsule
Human
2024-01-06
2011-08-23
2004-01-06
VYVANSE
Oral
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2527646
20 mg
Capsule
Human
2024-01-06
2011-08-23
2004-01-06
VYVANSE
Oral
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2527646
40 mg
Capsule
Human
2024-01-06
2011-08-23
2004-01-06
VYVANSE
Oral
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2527646
10mg
CAPSULE
Human
2024-01-06
2011-08-23
2004-01-06
VYVANSE
ORAL
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2527646
70 mg
CAPSULE
Human
2024-01-06
2011-08-23
2004-01-06
VYVANSE
ORAL
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY